Advanced glycation end-products in diabetic nephropathy

被引:0
作者
Sugiyama, S
Miyata, T
Horie, K
Iida, Y
Tsuyuki, M
Tanaka, H
Maeda, K
机构
[1] CHUKYO HOSP,DEPT ENDOCRINOL,MINAMI KU,NAGOYA,AICHI 457,JAPAN
[2] NAGOYA UNIV,SCH MED,BRANCH HOSP,DEPT INTERNAL MED,NAGOYA,AICHI 466,JAPAN
关键词
advanced glycation end-products; diabetes mellitus; end-stage renal failure; nephropathy;
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Advanced glycation end-products (AGEs) are the pigmented and fluorescent adduct formed by a non-enzymatic reaction between sugar and protein. Since AGEs are generated in high glucose milieu, then induce the structural and functional alteration of matnx proteins, and have biological effects on various kinds of cells including mesangial cells, AGEs have been implicated in tissue damage of diabetic nephrophathy. To elucidate the factor(s) that determine the AGEs level in diabetic nephrophathy, we quantitated the plasma pentosidine level of different status of diabetic nephrophathy by HPLC assay. The plasma pentosidine level in diabetic nephrophathy was found to be determined by factors such as renal function, control of glucose and the patient's age; of these, renal function was the most critical factor. For a better understanding of the pathological role of AGEs in diabetic nephrophathy, we then examined renal tissues of diabetic nephrophathy immunohistochemically using antibodies specific for AGE proteins. Immunohistochemistry revealed the positive immunostaining for AGEs in the expanded mesangial area of diffuse diabetic glomerulosclerosis. The degree of staining was stronger than that in patients of IgA nephropathy with a similar degree of mesangial expansion. The nodular lesions, characteristic of diabetic nephrophathy, were also stained positive for AGEs. These findings suggests a potential link of AGEs accumulation, which may be determined by renal function, control of glucose and age, to renal tissue damage in diabetic nephrophathy.
引用
收藏
页码:91 / 94
页数:4
相关论文
共 50 条
  • [1] Roles of advanced glycation end-products in the progression of diabetic nephropathy
    Makino, H
    Shikata, K
    Kushiro, M
    Hironaka, K
    Yamasaki, Y
    Sugimoto, H
    Ota, Z
    Araki, N
    Horiuchi, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 76 - 80
  • [2] Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
    Oshitari, Toshiyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [3] Advanced glycation end-products and the kidney
    Busch, Martin
    Franke, Sybille
    Ruester, Christiane
    Wolf, Gunter
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (08) : 742 - 755
  • [4] THE ROLE OF ADVANCED GLYCATION END PRODUCTS IN PATOGENESIS OF DIABETIC NEPHROPATHY
    Gavrilova, Alina O.
    Severina, Anastasia S.
    Shamhalova, Minara S.
    Shestakova, Marina, V
    DIABETES MELLITUS, 2021, 24 (05): : 461 - 469
  • [5] Hypoxia in the Diabetic Kidney Is Independent of Advanced Glycation End-Products
    Nordquist, Lina
    Liss, Per
    Fasching, Angelica
    Hansell, Peter
    Palm, Fredrik
    OXYGEN TRANSPORT TO TISSUE XXXIV, 2013, 765 : 185 - 193
  • [6] Advanced glycation end-products and the progress of diabetic vascular complications
    Jakus, V
    Rietbrock, N
    PHYSIOLOGICAL RESEARCH, 2004, 53 (02) : 131 - 142
  • [7] Assessment of advanced glycation end-products as a biomarker of diabetic outcomes
    Simo-Servat, Olga
    Planas, Alejandra
    Ciudin, Andreea
    Simo, Rafael
    Hernandez, Cristina
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (09): : 540 - 545
  • [8] Advanced glycation end-products: a review
    Singh, R
    Barden, A
    Mori, T
    Beilin, L
    DIABETOLOGIA, 2001, 44 (02) : 129 - 146
  • [9] Advanced glycation end-products: a review
    R. Singh
    A. Barden
    T. Mori
    L. Beilin
    Diabetologia, 2001, 44 : 129 - 146
  • [10] Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies
    Daroux, M.
    Prevost, G.
    Maillard-Lefebvre, H.
    Gaxatte, C.
    D'Agati, V. D.
    Schmidt, A. M.
    Boulanger, E.
    DIABETES & METABOLISM, 2010, 36 (01) : 1 - 10